Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “chronic myeloid leukemia”
Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00352677. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Flumatinib Efficacy and Safety for New Diagnosed Chronic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT04591197. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
ClinicalTrials.gov study NCT05353205. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-world Effectiveness of Asciminib and Treatment Patterns in Patients With Chronic Myeloid Leukemia With T315I Mutation - a Chart Review Study of Patients Treated in the Asciminib Managed Access Pr
ClinicalTrials.gov study NCT06211153. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
ClinicalTrials.gov study NCT06163430. IPD Sharing: NO. Countries: 9. Publications: 0.
ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT05007873. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00017472. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients
ClinicalTrials.gov study NCT07151820. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment
ClinicalTrials.gov study NCT07188428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-World Usage of Asciminib Among Patients With Chronic Myeloid Leukemia in Chronic Phase in the United States Using a Large Claims Database
ClinicalTrials.gov study NCT06148493. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis
ClinicalTrials.gov study NCT03831776. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous L
ClinicalTrials.gov study NCT00275080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan
ClinicalTrials.gov study NCT07150793. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT05367765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02782403. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leuk
ClinicalTrials.gov study NCT02225574. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00895297. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy
ClinicalTrials.gov study NCT01456676. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT01227356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02896829. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.